Prolacta Bioscience, Inc. Receives $20 Million Financing

Represented Prolacta Bioscience, Inc. in its $20 million equity financing by Health Evolution Partners.Prolacta Bioscience is a privately held, life sciences company dedicated to improving the quality of life in the most fragile infants through the harmony of nature and science. Prolacta Bioscience creates specialty formulations made from human milk for the nutritional needs of premature infants in Neonatal Intensive Care Units.